86 related articles for article (PubMed ID: 22936726)
21. Pharmacological profile of celecoxib, a specific cyclooxygenase-2 inhibitor.
Yoshino T; Kimoto A; Kobayashi S; Noguchi M; Fukunaga M; Hayashi A; Miyata K; Sasamata M
Arzneimittelforschung; 2005; 55(7):394-402. PubMed ID: 16080279
[TBL] [Abstract][Full Text] [Related]
22. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
23. Febrile response induced by cecal ligation and puncture (CLP) in rats: involvement of prostaglandin E2 and cytokines.
Figueiredo MJ; Soares DM; Martins JM; Machado Rde R; Sorgi CA; Faccioli LH; Melo MC; Malvar Ddo C; Souza GE
Med Microbiol Immunol; 2012 May; 201(2):219-29. PubMed ID: 22203392
[TBL] [Abstract][Full Text] [Related]
24. Cyclooxygenase-2/PGE2 pathway facilitates pentylenetetrazol-induced seizures.
Oliveira MS; Furian AF; Royes LF; Fighera MR; Fiorenza NG; Castelli M; Machado P; Bohrer D; Veiga M; Ferreira J; Cavalheiro EA; Mello CF
Epilepsy Res; 2008 Mar; 79(1):14-21. PubMed ID: 18255268
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of angiotensin II activity enhanced the antitumor effect of cyclooxygenase-2 inhibitors via insulin-like growth factor I receptor pathway.
Yasumaru M; Tsuji S; Tsujii M; Irie T; Komori M; Kimura A; Nishida T; Kakiuchi Y; Kawai N; Murata H; Horimoto M; Sasaki Y; Hayashi N; Kawano S; Hori M
Cancer Res; 2003 Oct; 63(20):6726-34. PubMed ID: 14583467
[TBL] [Abstract][Full Text] [Related]
26. Wound collagen deposition in rats: effects of an NO-NSAID and a selective COX-2 inhibitor.
Muscará MN; McKnight W; Asfaha S; Wallace JL
Br J Pharmacol; 2000 Feb; 129(4):681-6. PubMed ID: 10683192
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous application of peptidoglycan from Staphylococcus aureus induces eosinophil infiltration in mouse skin.
Matsui K; Wirotesangthong M; Nishikawa A
Clin Exp Allergy; 2007 Apr; 37(4):615-22. PubMed ID: 17430360
[TBL] [Abstract][Full Text] [Related]
28. Endotoxin fever in granulocytopenic rats: evidence that brain cyclooxygenase-2 is more important than circulating prostaglandin E(2).
Tavares E; Miñano FJ; Maldonado R; Dascombe MJ
J Leukoc Biol; 2006 Dec; 80(6):1375-87. PubMed ID: 16997862
[TBL] [Abstract][Full Text] [Related]
29. The effect of central angiotensin II receptor blockade on interleukin-1beta- and prostaglandin E-induced fevers in rats: possible involvement of brain angiotensin II receptor in fever induction.
Watanabe T; Saiki Y; Sakata Y
J Pharmacol Exp Ther; 1997 Aug; 282(2):873-81. PubMed ID: 9262354
[TBL] [Abstract][Full Text] [Related]
30. Prostaglandin D(2) sustains the pyrogenic effect of prostaglandin E(2).
Gao W; Schmidtko A; Lu R; Brenneis C; Angioni C; Schmidt R; Geisslinger G
Eur J Pharmacol; 2009 Apr; 608(1-3):28-31. PubMed ID: 19249295
[TBL] [Abstract][Full Text] [Related]
31. LPS induces eosinophil migration via CCR3 signaling through a mechanism independent of RANTES and Eotaxin.
Penido C; Castro-Faria-Neto HC; Vieira-de-Abreu A; Figueiredo RT; Pelled A; Martins MA; Jose PJ; Williams TJ; Bozza PT
Am J Respir Cell Mol Biol; 2001 Dec; 25(6):707-16. PubMed ID: 11726396
[TBL] [Abstract][Full Text] [Related]
32. Differential sensitivities of pyrogenic chemokine fevers to cyclooxygenase isozymes antibodies.
Tavares E; Miñano FJ
Brain Res Bull; 2002 Nov; 59(3):181-7. PubMed ID: 12431747
[TBL] [Abstract][Full Text] [Related]
33. Exogenous ghrelin attenuates endotoxin fever in rats.
Soriano RN; Nicoli LG; Carnio EC; Branco LG
Peptides; 2011 Nov; 32(11):2372-6. PubMed ID: 21377501
[TBL] [Abstract][Full Text] [Related]
34. Prostaglandin E(2) potentiates methylmalonate-induced seizures.
Salvadori MG; Banderó CR; Jesse AC; Gomes AT; Rambo LM; Bueno LM; Bortoluzzi VT; Oliveira MS; Mello CF
Epilepsia; 2012 Jan; 53(1):189-98. PubMed ID: 22091840
[TBL] [Abstract][Full Text] [Related]
35. Discovery of a novel COX-2 inhibitor as an orally potent anti-pyretic and anti-inflammatory drug: design, synthesis, and structure-activity relationship.
Hayashi S; Sumi Y; Ueno N; Murase A; Takada J
Biochem Pharmacol; 2011 Oct; 82(7):755-68. PubMed ID: 21741371
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of 2 celecoxib derivatives: analgesic effect and selectivity to cyclooxygenase-2/1.
Lu ZH; Xiong XY; Zhang BL; Lin GC; Shi YX; Liu ZG; Meng JR; Zhou YM; Mei QB
Acta Pharmacol Sin; 2005 Dec; 26(12):1505-11. PubMed ID: 16297351
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of cyclooxygenase-2 activity by celecoxib does not lead to radiosensitization of human prostate cancer cells in vitro.
Ohneseit PA; Krebiehl G; Dittmann K; Kehlbach R; Rodemann HP
Radiother Oncol; 2007 Feb; 82(2):229-38. PubMed ID: 17207548
[TBL] [Abstract][Full Text] [Related]
38. RANTES-mediated control of excitatory amino acid release in mouse spinal cord.
Di Prisco S; Summa M; Chellakudam V; Rossi PI; Pittaluga A
J Neurochem; 2012 May; 121(3):428-37. PubMed ID: 22385043
[TBL] [Abstract][Full Text] [Related]
39. Celecoxib reduces skin damage after radiation: selective reduction of chemokine and receptor mRNA expression in irradiated skin but not in irradiated mammary tumor.
Liang L; Hu D; Liu W; Williams JP; Okunieff P; Ding I
Am J Clin Oncol; 2003 Aug; 26(4):S114-21. PubMed ID: 12902868
[TBL] [Abstract][Full Text] [Related]
40. The cPLA2α inhibitor efipladib decreases nociceptive responses without affecting PGE2 levels in the cerebral spinal fluid.
Nickerson-Nutter CL; Goodwin D; Shen MW; Damphousse C; Duan W; Samad TA; McKew JC; Lee KL; Zaleska MM; Mollova N; Clark JD
Neuropharmacology; 2011 Mar; 60(4):633-41. PubMed ID: 21146550
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
